A Phase I Study of SSGJ-612 in Patients With Advanced Solid Tumors

Clinical trial NCT07032298 · RECRUITING

Trial details

NCT number: NCT07032298
Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Tumors

Start date: 2025-07-18
Primary completion: 2026-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.